about
Aerobic bacteria in post surgical wound infections and pattern of their antimicrobial susceptibility in Ayder Teaching and Referral Hospital, Mekelle, Ethiopia.Isolation and anti-microbial susceptibility pattern of group B Streptococcus among pregnant women attending antenatal clinics in Ayder Referral Hospital and Mekelle Health Center, Mekelle, Northern Ethiopia.Sero-prevalence and associated risk factors for hepatitis C virus infection among voluntary counseling testing and anti retroviral treatment clinic attendants in Adwa hospital, northern Ethiopia.Green synthesis of silver nanoparticles via plant extracts: beginning a new era in cancer theranostics.Ocular bacterial infections at Quiha Ophthalmic Hospital, Northern Ethiopia: an evaluation according to the risk factors and the antimicrobial susceptibility of bacterial isolates.Prevalence and risk factors of methicillin-resistant Staphylococcus aureus colonization among HIV patients in Mekelle, Northern Ethiopia.Green chemical synthesis of gold nanoparticles by using Penicillium aculeatum and their scolicidal activity against hydatid cyst protoscolices of Echinococcus granulosus.The prevalence and drug resistance pattern of extended spectrum β-lactamases (ESBLs) producing Enterobacteriaceae in Africa.Bacterial profile of ocular infections: a systematic review.Green synthesis of anisotropic zinc oxide nanoparticles with antibacterial and cytofriendly properties.Antimicrobial efficacy of drug blended biosynthesized colloidal gold nanoparticles from Justicia glauca against oral pathogens: A nanoantibiotic approach.Rapid biosynthesis of silver nanoparticles from Bacillus megaterium (NCIM 2326) and their antibacterial activity on multi drug resistant clinical pathogens.Biomimetic synthesis of silver nanoparticles from Streptomyces atrovirens and their potential anticancer activity against human breast cancer cells.Synthesis of silver nanoparticles from Bacillus brevis (NCIM 2533) and their antibacterial activity against pathogenic bacteria.Biosynthesis of silver nanoparticles from Staphylococcus aureus and its antimicrobial activity against MRSA and MRSE.Synthesis of silver nanoparticles from Phenerochaete chrysosporium (MTCC-787) and their antibacterial activity against human pathogenic bacteria.Biosynthesized colloidal silver and gold nanoparticles as emerging leishmanicidal agents: an insight.Green synthesis of silver nanoparticles using Rheum palmatum root extract and their antibacterial activity against Staphylococcus aureus and Pseudomonas aeruginosa.Antimicrobial efficacy of green synthesized drug blended silver nanoparticles against dental caries and periodontal disease causing microorganisms.Review on emergence of drug-resistant tuberculosis (MDR & XDR-TB) and its molecular diagnosis in Ethiopia.Extracellular synthesis of silver bionanoparticles from Aspergillus clavatus and its antimicrobial activity against MRSA and MRSESpecies, Risk Factors, and Antimicrobial Susceptibility Profiles of Bacterial Isolates from HIV-Infected Patients Suspected to Have Pneumonia in Mekelle Zone, Tigray, Northern Ethiopia.Prevalence and Factors Associated with Multidrug-Resistant Tuberculosis (MDR-TB) among Presumptive MDR-TB Patients in Tigray Region, Northern EthiopiaBacterial Isolates and Drug Susceptibility Pattern of Sterile Body Fluids from Tertiary Hospital, Northern Ethiopia: A Four-Year Retrospective StudyHIV prevalence and risk factors in infants born to HIV positive mothers, measured by dried blood spot real-time PCR assay in Tigray, Northern EthiopiaEmerging Antineoplastic Biogenic Gold Nanomaterials for Breast Cancer Therapeutics: A Systematic ReviewA Systematic Review on Drug Resistant Urinary Tract Infection Among Pregnant Women in Developing Countries in Africa and Asia; 2005-2016
P50
Q34151460-1D8100A1-0CD5-4867-839B-C0325AB15A56Q35795996-BAC25FA8-F9D5-4C44-9914-C2BA6B0B80ADQ35932185-469512D9-D7E3-4311-B0A3-D84FD8D40B19Q36181235-6017EFE2-0F0B-42D7-A9F3-13B3BBEE8608Q36307743-C14386BC-BA2B-4AFD-9A5F-323E98E8D3E5Q38819845-213F4D31-D30A-4294-8E8C-72D67BC7FB1EQ38892113-416E348E-90CF-480F-AA10-DC9D80089462Q46087235-9D8DE9B3-A647-45A9-9D4D-29B0628999C6Q46747284-F4E57CD3-792B-4914-8641-36838F5C0259Q47243111-86A83E4E-7013-4A0B-894E-B0A3B90A9114Q47860811-4466C172-9AD2-4713-A97C-0491D8661C45Q48621721-9D4B814B-FD60-464A-ADAB-E963271349B3Q49859954-FDAB3D84-9DE4-49EB-BA2B-38E96439AA63Q49924370-27B4451A-EAE0-49F1-9073-3A907FAE2208Q50054663-FD8FE4ED-04F6-4550-AA74-56B312479E55Q50086549-576FB12B-A8C8-413F-A906-59930A18B1C1Q50124215-0BA30BF2-B845-4E92-B8AF-043713E838F9Q50230826-18A7D951-9DBF-411C-8EF6-1709659F35EEQ50249963-B2CF6495-5BF8-4834-A36A-97A7E26C1271Q52683025-67BF22C2-C81A-4FE7-9996-FE9218C1752EQ56593699-1C06D7EE-83E5-481B-A871-CDDE66F85404Q64969747-175C1ED7-5C67-4A2C-82B1-31ACCAFFB0FFQ90469617-06A2BA12-F219-491F-BE87-593D6043800AQ91533403-E6FB233B-BEB8-4712-8C0E-6942CE8059C5Q92211312-05DF81FE-CD5C-44E6-87C5-716E5490F408Q96432577-D93CC3CF-1715-4148-B42C-4B3D5FA32715Q96432892-47101037-0B9F-40D4-BF60-8BC6CB4BB5F5
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Dr. M. Saravanan
@ast
Dr. M. Saravanan
@en
Dr. M. Saravanan
@es
Dr. M. Saravanan
@nl
type
label
Dr. M. Saravanan
@ast
Dr. M. Saravanan
@en
Dr. M. Saravanan
@es
Dr. M. Saravanan
@nl
prefLabel
Dr. M. Saravanan
@ast
Dr. M. Saravanan
@en
Dr. M. Saravanan
@es
Dr. M. Saravanan
@nl
P106
P31
P496
0000-0002-1480-3555